FDA Inspection 1178753 — Biogen U.S. Corporation

Biogen U.S. Corporation — FEI 3010164829

The FDA completed an inspection of Biogen U.S. Corporation on Aug 26, 2022 in Morrisville, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.